Schering cuts save €700m/year

Robinson, Simon; Williams, Dede
June 2006
ICIS Chemical Business;6/26/2006, Vol. 1 Issue 25, p10
Trade Publication
The article reports on the takeover of Schering by Bayer in June 2006. The takeover is considered the biggest and the most expensive deal in the company's history. At a joint news conference, Werner Wenning of Bayer rejected suggestions that Bayer had not moved fast enough to thwart Merck by buying stock outside the tender offer. INSET: SO LONG SCHERING.


Related Articles

  • Bayer Schering job cuts. William, Dede; Gibson, Jane // ICIS Chemical Business Americas;3/5/2007, Vol. 271 Issue 9, p13 

    This article reports that Schering is set to cut 950 jobs at its headquarters in Berlin, Germany by 2009. Werner Wenning, Bayer chairman, said the move is due to the merger between the pharmaceutical activities of Schering and Bayer. Wenning, who is also chairman of Bayer Schering Pharma's...

  • Bayer's Schering buy good move. Williams, Dede // ICIS Chemical Business;12/4/2006, Vol. 1 Issue 46, p10 

    The article focuses on the statement by Bayer chairman Werner Wenning regarding the impact of the acquisition of German drug maker Schering by Bayer. The consolidation of Schering contributed strongly to the expansion of quarterly sales, and Wenning said the takeover will boost full-year...

  • Bayer aims high for its 2009 targets. Williams, Dede; Watts, Mark // ICIS Chemical Business;3/19/2007, Vol. 2 Issue 58, p5 

    The article reveals that after buying Schering, Bayer has lifted its 2009 targets for earnings, capital expenditure, and research and development. According to Chairman Werner Wenning, Bayer's management is targeting an underlying margin of 22% for earnings before interest, tax, depreciation and...

  • Wrap-up.  // Chemical Week;1/29/97, Vol. 159 Issue 4, p25 

    Announces the appointment of Werner Wenning to Bayer's board of management effective February 1, 1997.

  • Sale of Merck's Shares Paves Way for Bayer to Buy Schering. Young, Ian // Chemical Week;6/21/2006, Vol. 168 Issue 21, p8 

    The article reports on the agreement of Merck KGaA to sell its stake in Schering to Bayer. The agreement means that Bayer will have to pay almost €17 billion for Schering, compared with the €16.5 billion it had originally offered. Bayer also announced that it had filed a lawsuit in...

  • Bayer Clinches Acquisition of Schering.  // Chemical Week;6/28/2006, Vol. 168 Issue 22, p5 

    The article reports on the acquisition of Schering by Bayer as of June 28, 2006. Shareholders representing majority of Schering's equity had accepted Bayer's offer by June 20. Bayer will merge its pharmaceuticals business with Schering to form Bayer Schering Pharma in Berlin, Germany. Its...

  • A cross to Bayer. Lerner, Ivan; Williams, Dede // ICIS Chemical Business;1/7/2008, Vol. 273 Issue 1, p42 

    The article reports that chemical firm Bayer's chairman and chief executive officer Werner Wenning, who was born and raised in Leverkusen, Germany, has announced on December 4, 2007 that the giant cross that has hung over the chemical site for more than 50 years would stay in place. The Bayer...

  • Bayer Considers Doubling Its Investment in Latin America. Thurston, Charles // Chemical Market Reporter;07/19/99, Vol. 256 Issue 3, p9 

    Focuses on the plan of Bayer AG to double its investment in Latin America up to 2004. Comment from Werner Wenning, management board representative of the firm in Latin America; Details on the investment plan; Information on the operation of the company.

  • New step for Bayer Schering.  // R&D Magazine;Jan2007, Vol. 49 Issue 1, p12 

    The article reports that Schering has been renamed to Bayer Schering Pharma AG following its acquisition by Bayer AG in July 2006. According to Werner Wenning, Bayer AG management board chairman, the firm is focusing on the next steps. Bayer Schering Pharma AG together with Bayer's...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics